sulfinpyrazone has been researched along with Bancroftian Elephantiasis in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flynn, AF | 1 |
| Joyce, MG | 1 |
| Taylor, RT | 1 |
| Bennuru, S | 1 |
| Lindrose, AR | 1 |
| Sterling, SL | 1 |
| Morris, CP | 1 |
| Nutman, TB | 1 |
| Mitre, E | 1 |
1 other study available for sulfinpyrazone and Bancroftian Elephantiasis
| Article | Year |
|---|---|
Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis.
Topics: Albendazole; Animals; Antigens, Helminth; Brugia malayi; Drug Therapy, Combination; Elephantiasis, F | 2019 |